Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RUTI vaccine as adjuvant to tuberculosis chemotherapy
NCT04919239Phase 2Completed
- Sponsor
- Archivel Farma
- Start
- Sep 2021
- Primary completion
- Jun 2025
- Modality
- Targeted Liposomes, Stealth (PEGylated) Liposomes, Conventional Liposomes
- Countries
- 1
01
Overview
A Phase 2 trial of RUTI vaccine in Tuberculosis (TB), sponsored by Archivel Farma. Started Sep 2021; status: completed.
02
Drugs
RUTI vaccine
03
Conditions
Tuberculosis (TB)
Beyond the preview
Go deeper on NCT04919239.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04919239.